TOP TIERMARKET NEWSWIRE
News & sentiment

MIRUM PHARMACEUTICAL (MIRM) — News & AI sentiment

MIRUM PHARMACEUTICAL (MIRM) news roundup. 5 stories in the past week, 7 over 30 days. Average 30-day sentiment is 55/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 10 sales totalling $13.4M — net selling of $13.4M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 54.8/100
30d stories
7
avg sentiment 55/100
Insider net (90d)
$13.4M
0 buys · 10 sells
Congress (90d)
0
0 buys · 0 sells

MIRM news in the last 24 hours, 7 days, 30 days and 90 days

How much MIRM coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowMIRM storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days554.8/100MIRM headlines →
Last 30 days755/100MIRM headlines →
Last 90 days2354.3/100MIRM headlines →

Latest stories on MIRM

3d ago
5d ago
5d ago
5d ago
5d ago
Sep 2
Citizens reiterates Mirum Pharmaceuticals stock rating on trial data
Investing.com Analyst Ratings56 · neutralanalyst
Aug 27
Aug 12
Aug 11
Aug 6
Aug 6
Aug 6
Aug 6
Aug 6
Aug 5
Aug 5
Jul 29
Jul 24
Jul 17
Jul 13
Jul 4
Jun 25
Jun 18
Jun 15
Jun 14
Open MIRM in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →